‘Current Innovations and the Future of Therapeutic ...

4
Indo-UK Virtual Conference ‘Current Innovations and the Future of Therapeutic Developments (CIFTD-2020)’ June 2020 Special event on June 2, Time: 2.00 to 4.00 PM A brain-storming panel discussion on ‘Challenges and Management of COVID-19’ Heads of reputed institutions, eminent scientists, clinicians, and policy makers are joining live for this panel discussion Centre for Biomaterials, Cellular & Molecular Theranostics (CBCMT). VIT, Vellore, India National Institute of Pharmaceutical Education & Research (NIPER), Kolkata, India Schrödinger Inc, Bengaluru, India In collaboration with Swansea University, Swansea United Kingdom 1 - 3 Free Registration Webinar

Transcript of ‘Current Innovations and the Future of Therapeutic ...

Indo-UK Virtual Conference‘Current Innovations and the Future of

Therapeutic Developments (CIFTD-2020)’

June2020

Special event on June 2, Time: 2.00 to 4.00 PMA brain-storming panel discussion on

‘Challenges and Management of COVID-19’Heads of reputed institutions, eminent scientists, clinicians, and policy

makers are joining live for this panel discussion

Centre for Biomaterials, Cellular & Molecular Theranostics

(CBCMT). VIT, Vellore, India

National Institute of Pharmaceutical Education &

Research (NIPER), Kolkata, India

Schrödinger Inc, Bengaluru, India

In collaboration with

Swansea University, Swansea

United Kingdom

1 - 3

Free Registration

Webinar

Chief Patron Dr. G. Viswanathan Founder & Chancellor, VIT

Patrons Mr. Sankar Viswanathan, Vice presidentDr. Sekar Viswanathan, Vice PresidentMr. G. V. Selvam, Vice PresidentMs. Kadhambari S. Viswanathan, Assistant Vice President Dr. Sandhya Pentareddy, Executive DirectorDr. Anand A Samuel, Vice ChancellorDr. S. Narayanan, Pro-Vice ChancellorDr. K. Sathiyanarayanan, Registrar

Conference ChairDr. Geetha ManivasagamDirector, CBCMT, VIT, VelloreProf. Venkat KanamarlapudiSwansea University Medical School, UK

ConvenersDr. Loganathan RangasamyCBCMT, VIT, Vellore Dr. Sudhagar Pitchaimuthu, Swansea University, United Kingdom

Organizing Team Members Dr. Arunai Nambi Raj NDr. Mohan Varma Damu SeshadriDr. Amit Kumar JaiswalDr. Arunkumar PalaniappanDr. Sunita NayakDr. Murugan RamalingamDr. Satyaprakash AhirwarDr. Raunak Kumar DasDr. Suya Prm Anand PResearch Scholars, CBCMT, VIT

ORGANIZING COMMITTEE The nationwide COVID-19 lockdown has forcedschools, colleges and universities to shut down. Inthese unprecedented times, to continue teachinglearning process, Vellore Institute of Technology(VIT) is offering a fantastic opportunity for e-learning through this International conference.VIT, Vellore, Tamil Nadu, INDIA and SwanseaUniversity, UK, proudly announce Indo-UK VirtualConference on 'Current Innovations and the Futureof Therapeutic Developments' to be held on June01-03, 2020 through Zoom platform. Thisconference will host leading scientists from theacademia and industry worldwide who will delivertheir talk on cutting edge advances in variousdisciplines on drug discovery, development ofnew medications and therapies. The focus of theconference will be on the interdisciplinaryapproaches at the interface of engineering anddiagnostics, chemistry, drug development, cellbiology and translational medicine. The conferenceaims to provide many interesting perspectives onhow science and technology of drug discovery anddrug therapy are changing rapidly, therebyproviding new opportunities to scientists andclinicians.A brain-storming panel discussion on ‘In search ofcoronavirus treatments – the opportunities andchallenges in India’ is an important component ofthis virtual conference. Heads of reputedinstitutions, eminent scientists, clinicians, andpolicy makers will address key questions such as,How India is dealing with the coronavirusoutbreak? What are the challenges in finding acure for coronavirus? What are the hurdles inbringing a drug for viral diseases? How India canplay a major role in a Covid-19 vaccinedevelopments?

During the three days, the participants will have theopportunity to learn about the latest researchtrends in pharmaceutical drug discovery anddevelopment.

ABOUT THE CONFERENCEAn opportunity will be given to 10 Ph.D students toshare their research outcome through oralpresentation. Prizes for the best talks and e-posterswill presented based on the reviewers’ evaluation.It is anticipated that at least 1500-2000 participantsfrom various parts of India will be joining in thismeeting. This webinar series targets B.Tech/M.Tech,masters, PhD research scholars, and early careerresearchers from chemistry, pharmaceutical,biomedical, life sciences, and nanotechnologydisciplines.

ABOUT VITVellore Institute of Technology (VIT), recognized asone of the Institution of Eminence (IoE) in 2019 byGovernment of India, was founded as VelloreEngineering College in 1984 by the ChancellorDr. G. Vishwanathan. VIT was awarded 1st positionamong private institutions in India for Innovation(ARIIA 2019 Award) by Govt. of India, as recognitionfor its excellence in nurturing research innovationsand entrepreneurship in young minds. VIT, knownfor its academic excellence, attracts students fromall the 29 states of India and more than 41 differentcountries. Currently, VIT has 4 campuses – inVellore, Chennai, Amaravati (AP) and Bhopal (MP).

VIT achieved 18th position among the engineeringinstitutions in India by NIRF 2019, Govt. of India. VITreceived 4 STAR rating in QS ranking, making it, thefirst institution in India to have this credential. Inaddition to this, the consortium of industries, FICCIconferred VIT with the “Excellence in Faculty”award. VIT was ranked number one ahead of otherpremier Indian universities for its number ofpublications in SCOPUS Indexed Research Journalsfor the year 2019. VIT has consistently received “A”grade in the past three cycles of NAACaccreditation. In addition, VIT also has received thecoveted ABET accreditation, which is widelyrecognized throughout the world. VIT, which isconsistently placed among the best institutions ofthe country, aspires to become one of the bestuniversities in the world.

Details regarding link to the webinar and password will be communicated to the registered email address by 31st May 2020

e-Certificates Participation certificate will be given to registered participants only who attend a minimum of 8 session.

Dates to remember: Last date for Registration: 30 May 2020Last date to submit abstract for oral presentation: 28th May 2020Last date to submit abstract for poster presentation and E-Posters: May 30, 2020

Centre for Biomaterials, Cellular and MolecularTheranostics (CBCMT) was established in the year2016 under the able leadership of Prof. GeethaManivasagam and is an integral part of VIT. Thisinterdisciplinary research center works on cuttingedge science at the interface of physical,biological, chemical and engineering sciences. Theresearch team comprise of material scientists,metallurgists, physicists, electrical engineers,bioengineers, chemists, biologists and clinicians,who work together to address the unmet needs inthe areas of biomaterials, cellular and moleculartheranostics. Some of the key focus areas includebone tissue engineering, biocorrosion andbiomechanics, cardiac tissue engineering, cornealtissue regeneration, drug discovery and delivery,quantum dots for theranostics, sensors formicrobial detection and implant health monitoring,and stem cell delivery. CBCMT is equipped withhigh-end instruments to carry out experimentsranging from materials synthesis, materialprocessing, characterizations as well as advancedtissue culture facilities. The recent addition to thiscenter, HOME (Human Organ Manufacturing andEngineering) Lab is an advanced 3D bioprintingfacility equipped with two high-end Cellink BioXbioprinters as well as few basic bioprinters. Withthis addition, center is better positioned tofabricate 3D organoids and tissue mimics, whichwill be also be one of the key focus areas incoming years. It is equipped with high endercharacterization instruments such as confocalmicroscope, cell culture lab, qPCr, Tribocorrosiontester, fretting wear tester, scratch tester,environmental controlled furnaces, alloy coatings,plasma treatment setup, and electrophoreticdeposition unit. The ongoing projects of the centerare funded by both national and internationalfunding agencies. The center also has a strongresearch collaboration with scientists from leadingresearch laboratories within India as well as acrossthe globe.

ABOUT CBCMT UG/PG students, PhD research scholars, and earlycareer researchers from chemistry,pharmaceutical, biomedical, life sciences, andnanotechnology disciplines, faculty members,scientist from R&D institutes, and industryresearchers

Oral presentation/e-Poster presentation fromResearch scholarsAbstracts for oral presentation or e-Postersrelated to the thematic areas of the Conference areinvited. Best oral and e-poster presentations willbe selected by a panel of judges and will beawarded

Oral presentation:v Abstracts must be submitted to oral

presentation.v Abstract will be considered from registered

participants only.v Abstract submission ends on May 28, 2020v There will be a selection committee to review

the abstracts based on its scientific merit fororal presentations. 10 best abstracts will beselected for oral presentations.

v The acceptance of abstract for Oralpresentations will be intimated to the delegateon May 30, 2020.

v Students/Research Fellows participating for theOral Presentation will be given 8 minutes for thepresentation and 2 minutes for the discussion.

v Oral presentation date: June 3, 2020

Poster Presentation GuidelinesAbstracts for e-poster presentation and e-Postersmust be submitted on or before May 30, 2020.

Registration and abstract submission:All participants are requested to fillhttps://forms.gle/4JX9KwEeu5oVU1fu6 on orbefore May 30, 2020. Use same link for abstractand poster submission.

Who can attend

Dr. Loganathan RangasamyIndian Convenor CBCMT, VIT, Vellore, Tamil Nadu, India Phone: [email protected]

Dr. Sudhagar PitchaimuthuUK Convenor Swansea University, Wales, United [email protected]

For any queries contact:Conference Email: [email protected] visit www.vit.ac.in

• Registration: Dr. Arunkumar, Email: [email protected] Phone: +919442231918

• Oral/poster presentation: Dr. Arunai Nambi Raj N, Email: [email protected]: +919443627064

• e-Certificate: Dr. Mohan Varma Damu Seshadri, Email: [email protected]: +91 9789846850

• Webinar queries: Dr. Amit Kumar Jaiswal, Email: [email protected] Phone: +919789280874

Address for correspondence

OUR SPEAKERS

Prof. Philip S. Low Purdue UniversityIndiana, USA

Dr. Ganesh Pandian NamasivayamKyoto University, Japan

Dr (Lt Col) Pawan Kumar Gupta, Stempeutics Research Pvt. Ltd.Bangalore, India

Dr. Andrea L. KasinskiPurdue University, Indiana, USA

Prof. Venkat KanamarlapudiSwansea University Medical SchoolSwansea, UK

Dr. Pritesh BhatSchrödinger IncBengaluru, Karnataka, India

Prof. Gareth JenkinsSwansea University, UK

Prof. Gilles GasserPSL University, Paris

Dr V. R. Ravi MS (Ortho) Mothercell Regenerative Centre

Tiruchirappalli, TN, India

A brain-storming panel discussion on ‘Challenges and Management of COVID-19’

Moderator : Dr. Murugan VeerapandianCentral ElectrochemicalResearch Institute,Karaikudi, TN, India.

Dr. V. RavichandiranDirector, NIPERKolkata, India

Dr. Taslimarif SaiyedCEO and Director (C-CAMP)Bangalore, Karnataka, India

Prof. Venkat KanamarlapudiProfessor Swansea University, UK

Prof. Dr. M. Krishnan Honourable Vice-Chancellor Madurai Kamaraj University

Madurai, TN, India

Dr. Ganesh Pandian NamasivayamAssociate Professor

Kyoto University, Japan

Dr. Swaminathan SethuNarayana Nethralaya

Karnataka, India.

Themesv Pharmaceutical

Research & Development

v Translational Medicine

v Regenerative Medicine

v Immunotherapyv Biomaterialsv Biosensorsv Tissue Engineeringv Nanotechnologyv Al in Drug

Discovery

v In-silico Drug Design and in-silico screening

v Medical Imagingv Hot Topics in

Medicinal Chemistry

v Drug Delivery & Targeting

v Academic CRO/Industrial collaborations in drug discovery

Dr. Jagathesh C.B. Rajendran,Masonic Medical Research Institute, Utica, New York.

Dr. Mahalingam S. M. SRM Institute of Science &Technology, Chennai, TN, India

Dr. Anitha DevadossSwansea University, UK

Dr. Sumit KumarUlsan National Institute of Science

and TechnologyUlsan, Republic of Korea

Panelists

Prof. Manish Khanna MS (Ortho)President, Indian Stem Cell Study

Group Association, Lucknow

Prof. Thomas J. Webster, Northeastern University,

Boston, USA